Tempus AI, Inc.
About Tempus AI, Inc.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.3B
- Net income
- -$245.0M
- Total assets
- $2.3B
- Market cap
- $8.3B
- Operating margin
- -19.9%
- Net margin
- -19.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.3B
- Operating expenses
- $1.5B
- Operating income
- -$252.9M
- Income tax
- -$51.7M
- Net income
- -$245.0M
- EPS (basic)
- $-1.41
- EPS (diluted)
- $-1.41
Balance sheet
- Total assets
- $2.3B
- Current assets
- $1.2B
- Total liabilities
- $1.8B
- Current liabilities
- $372.4M
- Shareholders’ equity
- $491.3M
Cash flow
- Operating cash flow
- -$218.1M
- Investing cash flow
- -$398.4M
- Financing cash flow
- $884.1M
- Net cash flow
- $267.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $8.3B
- EPS (diluted)
- $-1.41
- Shares outstanding
- 171.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 14, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $245.0M in FY2025.
- Revenue grew 83% from FY2024 to FY2025.
- Trading 53% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Tempus AI, Inc..
Write a review
News about Tempus AI, Inc.
News & sentiment via Polygon.io
